Amylyx Pharmaceuticals, Inc. (AMLX)
33.83
+0.08
(+0.24%)
USD |
NASDAQ |
Sep 01, 16:00
33.83
0.00 (0.00%)
After-Hours: 20:00
Amylyx Pharmaceuticals Cash and Short Term Investments (Quarterly) : 250.76M for June 30, 2026
Cash and Short Term Investments (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 250.76M |
| March 31, 2026 | 279.77M |
| December 31, 2025 | 316.98M |
| September 30, 2025 | 343.99M |
| June 30, 2025 | 180.83M |
| March 31, 2025 | 204.07M |
| December 31, 2024 | 176.50M |
| September 30, 2024 | 234.40M |
| June 30, 2024 | 309.81M |
| March 31, 2024 | 373.29M |
| December 31, 2023 | 371.36M |
| September 30, 2023 | 355.04M |
| Date | Value |
|---|---|
| June 30, 2023 | 357.28M |
| March 31, 2023 | 345.67M |
| December 31, 2022 | 346.94M |
| September 30, 2022 | 162.59M |
| June 30, 2022 | 206.68M |
| March 31, 2022 | 255.20M |
| December 31, 2021 | 96.12M |
| September 30, 2021 | 125.70M |
| June 30, 2021 | |
| March 31, 2021 | |
| December 31, 2020 | 12.88M |
| September 30, 2020 | 0.00 |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| Pfizer Inc. | 11.70B |
| Eli Lilly & Co. | 8.95B |
| Merck & Co., Inc. | 7.182B |
| EyePoint, Inc. | 180.47M |
| Bristol Myers Squibb Co. | 11.07B |